CD28 AND CTLA-4 HAVE OPPOSING EFFECTS ON THE RESPONSE OF T-CELLS TO STIMULATION

被引:1715
|
作者
KRUMMEL, MF
ALLISON, JP
机构
[1] UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA
[2] UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1995年 / 182卷 / 02期
关键词
D O I
10.1084/jem.182.2.459
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of the B7/CD28/CTLA-4 molecules has been established in studies of antigen-presenting cell-derived B7 and its interaction with the T cell costimulatory molecule CD28. CTLA-4, a T cell surface glycoprotein that is related to CD28, can also interact with B7-1 and B7-2. However, less is known about the function of CTLA-4, which is expressed at highest levels after activation. We have generated an antibody to CTLA-4 to investigate the consequences of engagement of this molecule in a carefully defined system using highly purified T cells. We show here that the presence of low levels of B7-2 on freshly explanted T cells can partially inhibit T cell proliferation, and this inhibition is mediated by interactions with CTLA-4. Cross-linking of CTLA-4 together with the TCR and CD28 strongly inhibits proliferation and IL-2 secretion by T cells. Finally, results show that CD28 and CTLA-4 deliver opposing signals that appear to be integrated by the T cell in determining the response to activation. These data strongly suggest that the outcome of T cell antigen receptor stimulation is regulated by CD28 costimulatory signals, as well as inhibitory signals derived from CTLA-4.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 50 条
  • [31] Peptides for elucidating the signal tranduction pathways of CTLA-4 and CD28
    Singleton, DH
    Gardner, JP
    Andrews, GC
    Fisher, TS
    Duerr, JM
    Guarino, BC
    Nunez, D
    Alegre, ML
    Neveu, MJ
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 602 - 603
  • [32] Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86
    Manzotti, CN
    Liu, M
    Burke, F
    Dussably, L
    Zheng, Y
    Sansom, DM
    IMMUNOLOGY, 2005, 116 : 6 - 6
  • [33] Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86
    Manzotti, Claire N.
    Liu, Michael X. P.
    Burke, Fiona
    Dussably, Laure
    Zheng, Yong
    Sansom, David M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (06) : 1413 - 1422
  • [34] Predictive and prognostic significance of T cell surface CD28 and CTLA-4 levels in hemophilia
    Li, Lingling
    Li, Xiumin
    Liu, Kai
    Xue, Jie
    Wang, Dongni
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (09): : 6297 - 6305
  • [35] CD28, HELPER T-CELLS, AND ANERGY
    MCARTHUR, JG
    ALLISON, JP
    RAULET, DH
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 59 - 59
  • [36] Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells
    Lazetic, S
    Leong, SR
    Chang, JCC
    Ong, R
    Dawes, G
    Punnonen, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) : 38660 - 38668
  • [37] STIMULATION OF CD28 TRIGGERS AN ASSOCIATION BETWEEN CD28 AND PHOSPHATIDYLINOSITOL 3-KINASE IN JURKAT T-CELLS
    TRUITT, KE
    HICKS, CM
    IMBODEN, JB
    JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03): : 1071 - 1076
  • [38] Different CD28/CTLA-4 homologues are required for the generation of natural and acquired CD4+CD25+regulatory T cells.
    Zheng, SG
    Wang, JH
    Stohl, W
    Kim, KS
    Horwitz, DA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S470 - S470
  • [39] CD28/CTLA-4 and CD80/CD86 familiesSignaling and function
    Jacqueline M. Slavik
    Jill E. Hutchcroft
    Barbara E. Bierer
    Immunologic Research, 1999, 19 : 1 - 24
  • [40] CD4(+) CD28(-) T-cells in multiple sclerosis patients
    Pinto-Medel, MJ
    Leyva, L
    Luque, G
    Mayorga, C
    Romero, F
    Blanco, E
    Bustamante, R
    Oliver, B
    León, A
    Fernáandez, O
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S164 - S164